Astal Laboratories Intrinsic Value
Astal Laboratories (ASTALLTD) median intrinsic value is ₹111.20 from 8 valuation models (range ₹36–₹152), vs current price ₹62.13 — +79.0% upside (Trading Below Calculated Value), margin of safety 44.1%. For current market price and key ratios, visit ASTALLTD stock price BSE.
ASTALLTD Valuation Methods Summary — DCF, Graham Number & P/E
Astal Laboratories intrinsic value across 8 models vs current price ₹62.13 — upside/downside and value range per method. Also explore ASTALLTD stock price history to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹114.00 | ₹91.20 - ₹136.80 | +83.5% | EPS: ₹9.50, Sector P/E: 12x |
| Book Value Method | asset | ₹36.00 | ₹32.40 - ₹39.60 | -42.1% | Book Value/Share: ₹36.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹111.20 | ₹100.08 - ₹122.32 | +79.0% | Revenue/Share: ₹139.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹90.00 | ₹81.00 - ₹99.00 | +44.9% | EBITDA: ₹15.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹152.00 | ₹136.80 - ₹167.20 | +144.6% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹81.70 | ₹73.53 - ₹89.87 | +31.5% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹124.26 | ₹111.83 - ₹136.69 | +100.0% | ROE: 27.8%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹72.00 | ₹64.80 - ₹79.20 | +15.9% | EPS: ₹9.50, BVPS: ₹36.00 |
ASTALLTD Intrinsic Value vs Market Price — All Valuation Models
Astal Laboratories fair value range ₹36–₹152 vs current market price ₹62.13 across 8 valuation models. Read ASTALLTD dividend track record for the complete payout history and dividend yield track record.
ASTALLTD Intrinsic Value Analysis — Undervalued or Overvalued?
Astal Laboratories median intrinsic value ₹111.20, current price ₹62.13 — Trading Below Calculated Value by 79.0%, margin of safety 44.1%.
What is the intrinsic value of ASTALLTD?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Astal Laboratories (ASTALLTD) is ₹111.20 (median value). With the current market price of ₹62.13, this represents a +79.0% variance from our estimated fair value.
The valuation range spans from ₹36.00 to ₹152.00, indicating ₹36.00 - ₹152.00.
Is ASTALLTD undervalued or overvalued?
Based on our multi-method analysis, Astal Laboratories (ASTALLTD) appears to be trading below calculated value by approximately 79.0%.
ASTALLTD Financial Health — Key Ratios vs Industry Benchmarks
Astal Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 46.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 27.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 12.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.21x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ASTALLTD Cash Flow Quality — Operating & Free Cash Flow
Astal Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-13 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-6 Cr | ₹-9 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |